Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY4P25 stands for "RNA, Ro-associated Y4 pseudogene 25," and is classified as a pseudogene of the Y RNA family. Y RNAs are a class of small non-coding RNAs involved in fundamental cellular processes, such as DNA replication and RNA stability, but pseudogenes themselves do not encode functionally active molecules. Specifically, RNY4P25 does not produce an active Y4 RNA; rather, it is a nonfunctional genomic sequence related to the gene encoding RNY4 (RNA, Ro-associated Y4), which is one of four functional human Y RNAs (RNY1, RNY3, RNY4, RNY5)[3][4]. Evidence suggests that several Y RNA genes have related pseudogenes, but there is no data supporting any specific function or biological activity for RNY4 pseudogene 25. Consequently, RNY4P25 is not a protein, receptor, enzyme, therapeutic target, or actionable biomarker. Searches reveal no experimental or clinical roles, disease associations, or drug interactions for this pseudogene[3][4]. Much of the biomedical literature on Y RNA refers to *functional* RNAs like RNY4, not their pseudogenes; studies describing disease links, cancer exosomes, or biomarker status are not referring to RNY4P25, but to the parent RNY4 transcript[1][4]. If you are seeking information on therapeutic targets or biologically active molecules, RNY4P25 should not be considered, as it is a non-expressed pseudogene lacking known function. Note: If the intent was to query the functional Y RNA gene "RNY4 (RNA, Ro-associated Y4)"—commonly discussed as involved in cancer, DNA replication, and as a potential biomarker—the information provided in sources applies to that gene, not to its pseudogenes such as RNY4P25[1][4]. If more details are needed for the active molecule, RNY4, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 25 (RNY4P25).